Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-016199
Filing Date
2018-03-21
Accepted
2018-03-21 17:07:54
Documents
60
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tv487473_10k.htm 10-K 560288
2 EXHIBIT 21.1 tv487473_ex21-1.htm EX-21.1 2309
3 EXHIBIT 23.1 tv487473_ex23-1.htm EX-23.1 2768
4 EXHIBIT 31.1 tv487473_ex31-1.htm EX-31.1 11551
5 EXHIBIT 31.2 tv487473_ex31-2.htm EX-31.2 11462
6 EXHIBIT 32.1 tv487473_ex32-1.htm EX-32.1 4578
7 EXHIBIT 32.2 tv487473_ex32-2.htm EX-32.2 4619
  Complete submission text file 0001144204-18-016199.txt   2991534

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT enzn-20171231.xml EX-101.INS 523287
9 XBRL TAXONOMY EXTENSION SCHEMA enzn-20171231.xsd EX-101.SCH 35953
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20171231_cal.xml EX-101.CAL 25616
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20171231_def.xml EX-101.DEF 177116
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20171231_lab.xml EX-101.LAB 233210
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20171231_pre.xml EX-101.PRE 212384
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36435 | Film No.: 18705091
SIC: 2836 Biological Products, (No Diagnostic Substances)